Index NDX, S&P 500
P/E 46.00
EPS (ttm) 4.71
Insider Own 6.49%
Shs Outstand 77.27M
Perf Week 0.18%
Market Cap 16.61B
Forward P/E 23.30
EPS next Y 9.31
Insider Trans 0.21%
Shs Float 71.61M
Perf Month 9.66%
Income 362.81M
PEG 1.06
EPS next Q 2.20
Inst Own 88.09%
Short Float / Ratio 4.10% / 2.80
Perf Quarter -36.39%
Sales 3.81B
P/S 4.36
EPS this Y 8.17%
Inst Trans -1.42%
Short Interest 2.94M
Perf Half Y -28.12%
Book/sh 49.64
P/B 4.37
EPS next Y 10.87%
ROA 5.93%
Target Price 275.47
Perf Year 15.41%
Cash/sh 16.76
P/C 12.94
EPS next 5Y 43.25%
ROE 9.68%
52W Range 176.34 - 413.20
Perf YTD 2.83%
Dividend -
P/FCF 24.21
EPS past 5Y 10.25%
ROI 9.30%
52W High -47.51%
Beta 1.62
Dividend % -
Quick Ratio 1.13
Sales past 5Y 22.59%
Gross Margin 70.25%
52W Low 22.98%
ATR 7.68
Employees 23165
Current Ratio 1.27
Sales Q/Q 7.85%
Oper. Margin 15.65%
RSI (14) 48.04
Volatility 3.26% 2.96%
Optionable Yes
Debt/Eq 0.03
EPS Q/Q 70.09%
Profit Margin 9.53%
Rel Volume 0.70
Prev Close 215.35
Shortable Yes
LT Debt/Eq 0.03
Earnings Oct 25 AMC
Payout 0.00%
Avg Volume 1.05M
Price 216.87
Recom 1.81
SMA20 4.18%
SMA50 -8.69%
SMA200 -29.29%
Volume 749,080
Change 0.71%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-27-23 Downgrade
UBS
Buy → Neutral
$200
Feb-02-23 Upgrade
Goldman
Sell → Neutral
$165 → $307
Jul-28-22 Downgrade
Goldman
Buy → Sell
$380 → $250
Jan-31-22 Upgrade
UBS
Neutral → Buy
$880 → $620
Jan-31-22 Initiated
Morgan Stanley
Overweight
$575
Oct-01-21 Resumed
Credit Suisse
Outperform
$732
Aug-05-21 Resumed
Credit Suisse
Outperform
$732
Jul-09-21 Upgrade
Stephens
Equal-Weight → Overweight
$600 → $700
Jul-08-21 Initiated
Exane BNP Paribas
Outperform
$790
Apr-22-21 Upgrade
Berenberg
Hold → Buy
$683
Jan-04-21 Upgrade
Evercore ISI
In-line → Outperform
$625
Jul-29-20 Downgrade
Berenberg
Buy → Hold
$306
Jul-20-20 Downgrade
BofA Securities
Neutral → Underperform
$280
Jan-09-20 Upgrade
Wolfe Research
Peer Perform → Outperform
Oct-24-19 Reiterated
BofA/Merrill
Neutral
$220 → $240
Oct-07-19 Downgrade
Guggenheim
Buy → Neutral
Jul-25-19 Downgrade
Evercore ISI
Outperform → In-line
$340 → $220
May-30-19 Initiated
Wolfe Research
Peer Perform
Apr-18-19 Initiated
Guggenheim
Buy
Feb-14-19 Downgrade
UBS
Buy → Neutral
$275
Show Previous Ratings
Dec-06-23 08:08AM
Dec-05-23 04:01PM
Nov-24-23 11:31AM
Nov-22-23 05:50AM
Nov-14-23 01:35AM
09:03AM
Loading…
Nov-08-23 09:03AM
07:50AM
Nov-06-23 04:01PM
12:18PM
08:30AM
01:13AM
Nov-04-23 01:05AM
Nov-03-23 08:30AM
Oct-31-23 03:13AM
02:15AM
09:20AM
Loading…
Oct-27-23 09:20AM
08:30AM
Oct-26-23 05:05PM
04:25PM
03:05PM
01:20PM
01:02PM
12:53PM
11:43AM
11:40AM
11:05AM
(The Wall Street Journal)
10:02AM
10:00AM
09:52AM
09:11AM
(Investor's Business Daily)
08:48AM
Loading…
08:48AM
07:18AM
07:14AM
06:53AM
(Thomson Reuters StreetEvents)
05:47AM
Oct-25-23 11:16PM
(American City Business Journals)
10:30PM
06:28PM
05:30PM
05:15PM
05:15PM
05:13PM
04:20PM
04:13PM
(Associated Press Finance)
Oct-20-23 08:40AM
Oct-19-23 10:01AM
Oct-18-23 11:05AM
10:01AM
Oct-16-23 09:40AM
Oct-13-23 07:57AM
Oct-12-23 06:55PM
Oct-11-23 12:04PM
09:35AM
Oct-10-23 09:50AM
Oct-05-23 12:02PM
11:35AM
Oct-04-23 08:30AM
Oct-02-23 10:36AM
Sep-29-23 06:19PM
06:19PM
09:40AM
Sep-27-23 07:47AM
Sep-26-23 11:40AM
11:38AM
Sep-25-23 12:08PM
Sep-22-23 09:37AM
09:35AM
Sep-20-23 01:59PM
01:03PM
12:32PM
Sep-19-23 04:00PM
11:10AM
Sep-13-23 09:40AM
09:35AM
Sep-12-23 02:25PM
Sep-11-23 12:03PM
10:33AM
Sep-07-23 06:49PM
12:06PM
11:35AM
11:29AM
Sep-06-23 04:00PM
04:00PM
04:00PM
04:00PM
04:00PM
04:00PM
04:00PM
11:30AM
Aug-31-23 08:19AM
Aug-30-23 09:49AM
05:05AM
Aug-28-23 12:03PM
09:40AM
Aug-25-23 11:31AM
Aug-23-23 08:33PM
12:20PM
09:30AM
08:30AM
Aug-22-23 07:31PM
Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HOGAN JOSEPH M President and CEO Nov 09 Buy 192.50 5,194 999,845 208,664 Nov 09 08:35 PM HOGAN JOSEPH M President and CEO Oct 31 Buy 188.00 5,319 999,972 203,470 Nov 01 05:18 PM Coletti Julie Ann EVP, Chief Legal & Regulatory Jul 20 Option Exercise 0.00 320 0 2,898 Jul 24 06:23 PM Dallas Kevin J Director May 30 Buy 285.26 7,000 1,996,800 12,246 May 31 05:04 PM Thaler Warren S Director May 17 Option Exercise 0.00 1,114 0 31,780 May 19 05:33 PM SANTORA GREG J Director May 17 Option Exercise 0.00 1,114 0 11,987 May 19 05:30 PM Saia Andrea Lynn Director May 17 Option Exercise 0.00 1,114 0 13,396 May 19 05:28 PM Myong Anne Director May 17 Option Exercise 0.00 1,114 0 5,908 May 19 05:27 PM MORROW GEORGE J Director May 17 Option Exercise 0.00 1,114 0 1,114 May 19 05:25 PM LARKIN C RAYMOND JR Director May 17 Option Exercise 0.00 1,486 0 20,375 May 19 05:24 PM LACOB JOSEPH Director May 17 Option Exercise 0.00 1,114 0 156,994 May 19 05:23 PM Dallas Kevin J Director May 17 Option Exercise 0.00 1,114 0 5,246 May 19 05:21 PM Wright Emory EVP, Global Operations Feb 20 Option Exercise 0.00 3,371 0 8,350 Feb 23 08:17 PM Morici John EVP & Chief Financial Officer Feb 20 Option Exercise 0.00 3,846 0 12,050 Feb 23 08:15 PM HOGAN JOSEPH M President and CEO Feb 20 Option Exercise 0.00 17,625 0 206,042 Feb 23 08:14 PM Hockridge Stuart A EVP Global HR Feb 20 Option Exercise 0.00 2,790 0 9,194 Feb 23 08:12 PM Coletti Julie Ann EVP, Chief Legal & Regulatory Feb 20 Option Exercise 0.00 2,600 0 3,731 Feb 23 08:10 PM HOGAN JOSEPH M President and CEO Feb 08 Buy 341.50 2,928 999,912 188,417 Feb 09 09:03 PM Morici John EVP & Chief Financial Officer Feb 08 Buy 341.84 587 200,660 8,204 Feb 09 09:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite